ANTI-HTLV-I p19 SUPPRESSES HTLV-I AG EXPRESSION IN PERIPHERAL BLOOD LYMPHOCYTES FROM HTLV-I CARRJERS
Anti-HTLV-I antibodies possess an inhibitory action for HTLV-I infection. In cases where cells persistently expressing HTLV-I antigen are the source of infection m an in vitro system, antibodies against HTLV-I env antigens (such as anti-HTLV-I gp46 175-199 antibody, etc.) have an inhibitory action for HTLV-I cell to cell infection.
openaire
A. Rossi +6 more
semanticscholar +1 more source
Emerging virus coinfections of the CNS: HTLV I/II as a common denominator [PDF]
Christina Sklavou +7 more
core +1 more source
Self-management of HTLV-1-associated myelopathy/tropical spastic paraparesis in Japan: A qualitative study. [PDF]
Yamaguchi S, Yatsushiro R.
europepmc +1 more source
Rapidly Progressive and Relapsing Myelitis With Human T Lymphotropic Virus Type 1: A Case Report and Review of the Literature. [PDF]
Morrison AA, Samudralwar RD, Berger JR.
europepmc +1 more source
HIV/HTLV-1/2 Co-Infection in the Peruvian Amazon: Prevalence and Associated Factors. [PDF]
Alava-Flores WG +4 more
europepmc +1 more source
Epidemiology and Clinical Outcomes of HTLV-1: A Comprehensive Narrative Review of Endemic and Nonendemic Regions. [PDF]
Noori B +5 more
europepmc +1 more source
HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. [PDF]
Kasamatsu D +4 more
europepmc +1 more source
Clinical outcomes-dependent IgG epitope profiling in HTLV-1 reveals differential recognition of pathogen-derived antigens. [PDF]
Cilento NE +9 more
europepmc +1 more source

